Related Experiment Video
Updated: Aug 1, 2026

A Periprosthetic Joint Candida albicans Infection Model in Mouse
Published on: February 2, 2024
Fungal infections in ventricular assist devices
S P Goldberg1, J W Baddley, M F Aaron
1Department of Medicine, University of Alabama at Birmingham, 35294-0007, USA.
Abstract:
Device infections in patients supported by a mechanical circulatory support system remain an important problem, particularly as we enter the era of permanent device implantation. This article focuses on fungal infections that occur in patients with ventricular assist devices. The nature of fungal, especially Candida species, colonization and infection in severely ill, hospitalized patients will be described. Information regarding the effect of the artificial surface-blood interface on the immune system's ability to combat fungal organisms will also be presented. Basic aspects of the fungal-host interaction serve as the foundation for a discussion of clinical management protocols for preventing and treating fungal infections in patients supported by a ventricular assist device.
Insights
Fungal infections are a significant risk for patients with mechanical circulatory support devices. This review covers Candida infections, immune system effects, and management strategies for ventricular assist device patients.
Area of Science:
- Medical Mycology
- Infectious Diseases
- Cardiovascular Surgery
Background:
- Device infections pose a critical challenge for patients with mechanical circulatory support systems, especially with increasing permanent device use.
- Fungal infections, particularly those caused by Candida species, are a serious concern in critically ill, hospitalized patients requiring these devices.
Purpose of the Study:
- To review the nature of fungal colonization and infection in patients with ventricular assist devices (VADs).
- To explore the impact of the artificial surface-blood interface on the immune system's response to fungal organisms.
- To provide a foundation for understanding fungal-host interactions and inform clinical management strategies.
Main Methods:
- Literature review focusing on fungal infections in VAD patients.
- Analysis of the effects of artificial surfaces on host immunity.
- Synthesis of current knowledge on fungal-host interactions.
Main Results:
- Candida species are a primary cause of fungal infections in VAD recipients.
- The artificial surface-blood interface can impair the immune system's ability to fight fungal infections.
- Understanding fungal-host interactions is crucial for effective management.
Conclusions:
- Fungal infections, especially Candida, are a major complication in ventricular assist device patients.
- Management strategies must address the unique challenges posed by the artificial device-blood interface and host immune status.
- Preventing and treating these infections requires a comprehensive approach based on fungal biology and clinical presentation.
Related Concept Videos
Endocarditis I: Introduction
Endocarditis III: Medical Management
Endocarditis IV: Nursing Management
Cardiomyopathy V: Interprofessional Care
Cryptococcal Meningitis
Candidiasis

